Mason Street Advisors’s NeoGenomics NEO Stock Holding History

Mason Street Advisors’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-41,404	Closed	-$2.23M	–	806
2020 Q4	$2.23M	Sell	41,404 -27	-0.1%	-$1.22K	0.04%	560
2020 Q3	$1.53M	Buy	41,431 +211	+0.5%	+$7.84K	0.03%	647
2020 Q2	$1.28M	Buy	41,220 +4,854	+13%	+$135K	0.03%	713
2020 Q1	$1M	Hold	36,366	–	–	0.02%	725
2019 Q4	$1.06M	Buy	36,366 +1,100	+3%	+$26.2K	0.02%	859
2019 Q3	$674K	Buy	35,266 +1,062	+3%	+$24.9K	0.01%	1001
2019 Q2	$750K	Buy	34,204 +3,833	+13%	+$84.1K	0.02%	970
2019 Q1	$621K	Buy	+30,371	New	+$528K	0.01%	1058

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

Mason Street Advisors's NEO Position: Q1 2021 in Review

Mason Street Advisors sold out of NeoGenomics (NEO) in Q1 2021, closing a stake of 41,404 shares — an estimated $2.23M sold.

Mason Street Advisors first reported a position in NEO in Q1 2019 and held it in 8 quarters. The position peaked at $2.23M in Q4 2020. 332 funds tracked by Wall St. Rank hold NEO as of Q1 2021.

Mason Street Advisors reported no remaining NeoGenomics position as of Q1 2021 after selling out during the quarter.
Mason Street Advisors sold 41,404 NeoGenomics shares in Q1 2021, an estimated $2.23M.
Mason Street Advisors first reported a position in NeoGenomics in Q1 2019 and held it in 8 quarters.
Mason Street Advisors's NeoGenomics position peaked at $2.23M in Q4 2020.
332 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2021.

Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.